Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR
Clinical Genetic Test
offered by
GTR Test Accession: Help GTR000571362.2
Last updated in GTR: 2022-12-21
Last annual review date for the lab: 2022-12-28 Past due LinkOut
At a Glance
Predictive; Diagnosis; Drug Response; ...
Thrombocythemia 1; Acute lymphoid leukemia; Acute myeloid leukemia; ...
ABL1 (9q34.12), AKT1 (14q32.33), AKT2 (19q13.2), AKT3 (1q43-44), ALK (2p23.2-23.1), ...
Molecular Genetics - Targeted variant analysis: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Myeloproliferative neoplasms, Acute myeloid leukemia, Hematological neoplasms and associated syndromes
Not provided
Not provided
Ordering Information
Test short name: Help
Specimen Source: Help
Who can order: Help
  • Health Care Provider
Test Order Code: Help
View other test codes
CPT codes: Help
**AMA CPT codes notice
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Test development: Help
Test developed by laboratory (no manufacturer test name)
Informed consent required: Help
Pre-test genetic counseling required: Help
Post-test genetic counseling required: Help
Recommended fields not provided:
Conditions Help
Total conditions: 16
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 160
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Total methods: 1
Method Category Help
Test method Help
Instrument *
Targeted variant analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Predictive; Diagnosis; Drug Response; Prognostic
Target population: Help
Myeloproliferative neoplasms, Acute myeloid leukemia, Hematological neoplasms and associated syndromes
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
Analytic sensitivity >99% when variant is present at >5% VAF (FFPE requires minimum of 20% tumor cells). Analytic specificity of >99%. Precision and reproducibility of >98%.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Category: FDA exercises enforcement discretion
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.